Agency Forms Undergoing Paperwork Reduction Act Review, 4165-4166 [2014-01409]

Download as PDF Federal Register / Vol. 79, No. 16 / Friday, January 24, 2014 / Notices technology to minimize the information collection burden. Darius Taylor, Deputy, Information Collection Clearance Officer. [FR Doc. 2014–01415 Filed 1–23–14; 8:45 am] BILLING CODE 4150–28–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Presidential Advisory Council on HIV/AIDS Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: As stipulated by the Federal Advisory Committee Act, the U.S. Department of Health and Human Service (DHHS) is hereby giving notice that the Presidential Advisory Council on HIV/AIDS (PACHA) will hold a meeting; the primary topic of discussion will be the Ryan White Program. The meeting will be open to the public. DATES: The meeting will be held on February 27, 2014 from 9 a.m. to approximately 3 p.m. (EDT) and February 28, 2014 from 9 a.m. to approximately 12:30 p.m. (EDT). ADDRESSES: U.S. Department of Health and Human Services, 200 Independence Avenue SW., Washington, DC 20201 in the Auditorium on February 27 and in the John M. Eisenberg Memorial Room (The Penthouse) on February 28, 2014. FOR FURTHER INFORMATION CONTACT: Ms. Caroline Talev, Public Health Analyst, Presidential Advisory Council on HIV/ AIDS, U.S. Department of Health and Human Services, 200 Independence Avenue SW., Room 443H, Washington, DC 20201; (202) 205–1178. More detailed information about PACHA can be obtained by accessing the Council’s Web site www.aids.gov/pacha. SUPPLEMENTARY INFORMATION: PACHA was established by Executive Order 12963, dated June 14, 1995 as amended by Executive Order 13009, dated June 14, 1996. The Council was established to provide advice, information, and recommendations to the Secretary regarding programs and policies intended to promote effective prevention of HIV disease and AIDS. The functions of the Council are solely advisory in nature. The Council consists of not more than 25 members. Council members are selected from prominent community TKELLEY on DSK3SPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 16:22 Jan 23, 2014 Jkt 232001 leaders with particular expertise in, or knowledge of, matters concerning HIV and AIDS, public health, global health, philanthropy, marketing or business, as well as other national leaders held in high esteem from other sectors of society. Council members are appointed by the Secretary or designee, in consultation with the White House Office on National AIDS Policy. The agenda for the upcoming meeting will be posted on the Council’s Web site at www.aids.gov/pacha. Public attendance at the meeting is limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact person. Due to space constraints, pre-registration for public attendance is advisable and can be accomplished by contacting Caroline Talev at caroline.talev@hhs.gov by close of business Wednesday, February 12, 2014. Members of the public will have the opportunity to provide comments at the meeting. Any individual who wishes to participate in the public comment session must register with Caroline Talev at caroline.talev@hhs.gov by close of business Wednesday, February 12, 2014; registration for public comment will not be accepted by telephone. Individuals are encouraged to provide a written statement of any public comment(s) for accurate minute taking purposes. Public comment will be limited to two minutes per speaker. Any members of the public who wish to have printed material distributed to PACHA members at the meeting should submit, at a minimum, 1 copy of the material(s) to Caroline Talev, no later than close of business February 12, 2014. Dated: January 9, 2014. B. Kaye Hayes, Executive Director, Presidential Advisory Council on HIV/AIDS. [FR Doc. 2014–01360 Filed 1–23–14; 8:45 am] BILLING CODE 4150–43–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30-Day–14–0881] Agency Forms Undergoing Paperwork Reduction Act Review information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call (404) 639–7570 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. Proposed Project Data Calls for the Laboratory Response Network—Extension—(OMB No. 0920–0881, expires 3/31/14)— National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC). Background and Brief Description The Laboratory Response Network (LRN) was established by the Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) in accordance with Presidential Decision Directive 39, which outlined national anti-terrorism policies and assigned specific missions to Federal departments and agencies. The LRN’s mission is to maintain an integrated national and international network of laboratories that can respond to acts of biological, chemical, or radiological terrorism and other public health emergencies. Federal, State, and local public health laboratories voluntarily join the LRN. The LRN Program Office maintains a database of information for each member laboratory that includes contact information as well as staff and equipment inventories. However, semiannually or during emergency response, the LRN Program Office may conduct a Special Data Call to obtain additional information from LRN Member Laboratories in regards to biological or chemical terrorism preparedness. Special Data Calls may be conducted via queries that are distributed by broadcast emails or by survey tools (i.e. Survey Monkey). This is a request for an extension to this generic clearance. The only cost to respondents is their time to respond to the data call. The total annual burden hours requested is 400 hours. The Centers for Disease Control and Prevention (CDC) publishes a list of PO 00000 Frm 00016 Fmt 4703 Sfmt 4703 4165 E:\FR\FM\24JAN1.SGM 24JAN1 4166 Federal Register / Vol. 79, No. 16 / Friday, January 24, 2014 / Notices ESTIMATED ANNUALIZED BURDEN HOURS Type of respondents No. of responses per respondent No. of respondents Form name Avg. Burden per response (in hrs.) 4 30/60 Public Health Laboratorians ............................. Special Data Call Leroy Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. 2014. If you have never attended a Connect Pro event before, test your connection at https:// collaboration.fda.gov/common/help/en/ FOR FURTHER INFORMATION CONTACT: support/meeting_test.htm. To get a Geetha Jayan, Center for Devices and quick overview of the Connect Pro Radiological Health, Food and Drug program, visit https://www.adobe.com/ Administration, 10903 New Hampshire go/connectpro_overview. (FDA has Ave., Bldg. 66, rm. 3622, Silver Spring, verified the Web site addresses in this MD 20903–0002, 301–796–6300, email: document, but FDA is not responsible geetha.jayan@fda.hhs.gov. for any subsequent changes to the Web SUPPLEMENTARY INFORMATION: sites after this document publishes in Registration: Registration is free and the Federal Register.) available on a first-come, first-served Comments: FDA is holding this public basis. Persons interested in attending workshop to obtain information on this public workshop must register biofilms and anti-biofilm technology on online by 5 p.m. February 7, 2014. Early medical devices. In order to permit the registration is recommended because widest possible opportunity to obtain facilities are limited and, therefore, FDA public comment, FDA is soliciting may limit the number of participants either electronic or written comments from each organization. If time and on all aspects of the public workshop space permit, onsite registration on the topics. The deadline for submitting day of the public workshop will be comments related to this public provided beginning at 7 a.m. workshop is March 20, 2014. If you need special accommodations Regardless of attendance at the public due to a disability, please contact Susan workshop, interested persons may Monahan, (email: susan.monahan@ submit either electronic comments fda.hhs.gov or phone: 301–796–5661) no regarding this document to https:// later than February 7, 2014. www.regulations.gov or written To register for the public workshop, comments to the Division of Dockets please visit FDA’s Medical Devices Management (HFA–305), Food and Drug News & Events—Workshops & Administration, 5630 Fishers Lane, rm. Conferences calendar at https:// 1061, Rockville, MD 20852. It is only www.fda.gov/MedicalDevices/ necessary to send one set of comments. NewsEvents/WorkshopsConferences/ Identify comments with the docket default.htm. (Select this public number found in brackets in the workshop from the posted events list.) heading of this document. In addition, Please provide complete contact when responding to specific questions information for each attendee, including as outlined in section II, please identify name, title, affiliation, email, and the question you are addressing. telephone number. Those without Received comments may be seen in the Internet access should contact Susan Division of Dockets Management Monahan to register. Registrants will between 9 a.m. and 4 p.m., Monday receive confirmation after they have through Friday and will be posted to the been accepted. You will be notified if docket at https://www.regulations.gov. Transcripts: Please be advised that as you are on a waiting list. soon as a transcript is available, it will Streaming Webcast of the Public be accessible at https:// Workshop: This public workshop will www.regulations.gov. It may be viewed also be Webcast. Persons interested in at the Division of Dockets Management viewing the Webcast must register (see Comments). A transcript will also online by 5 p.m. (EST) on February 6, 2014. Early registration is recommended be available in either hardcopy or on CD–ROM, after submission of a because Webcast connections are Freedom of Information request. Written limited. Organizations are requested to requests are to be sent to the Division register all participants, but to view of Freedom of Information (ELEM– using one connection per location. 1029), Food and Drug Administration, Webcast participants will be sent 12420 Parklawn Dr., Element Bldg., technical system requirements after registration and will be sent connection Rockville, MD 20857. A link to the transcripts will also be available access information after February 14, [FR Doc. 2014–01409 Filed 1–23–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2014–N–0056] Biofilms, Medical Devices, and AntiBiofilm Technology—Challenges and Opportunities; Public Workshop; Request for Comments AGENCY: Food and Drug Administration, HHS. Notice of public workshop; request for comments. ACTION: The Food and Drug Administration (FDA) is announcing the following public workshop entitled ‘‘Biofilms, Medical Devices, and Anti-Biofilm Technology—Challenges and Opportunities.’’ FDA is cosponsoring this workshop with the Center for Biofilm Engineering of Montana State University. The purpose of the public workshop is to initiate dialogue between academia, industry, and U.S. Government scientists on the science of developing products to address biofilm formation. Topics of discussion include current scientific and medical research on biofilms, their impact on medical devices, and biofilm prevention strategies and their public health impact. The public workshop will be held on February 20, 2014, from 8 a.m. to 5 p.m. ADDRESSES: The public workshop will be held at FDA’s White Oak Campus, 10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room (rm. 1503A), Silver Spring, MD 20993–0002. Entrance for the public workshop participants (non-FDA employees) is through Building 1 where routine security check procedures will be performed. For parking and security information, please refer to https:// www.fda.gov/AboutFDA/ TKELLEY on DSK3SPTVN1PROD with NOTICES DATES: VerDate Mar<15>2010 16:22 Jan 23, 2014 Jkt 232001 200 WorkingatFDA/BuildingsandFacilities/ WhiteOakCampusInformation/ ucm241740.htm. PO 00000 Frm 00017 Fmt 4703 Sfmt 4703 E:\FR\FM\24JAN1.SGM 24JAN1

Agencies

[Federal Register Volume 79, Number 16 (Friday, January 24, 2014)]
[Notices]
[Pages 4165-4166]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-01409]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30-Day-14-0881]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
(404) 639-7570 or send an email to omb@cdc.gov. Send written comments 
to CDC Desk Officer, Office of Management and Budget, Washington, DC 
20503 or by fax to (202) 395-5806. Written comments should be received 
within 30 days of this notice.

Proposed Project

    Data Calls for the Laboratory Response Network--Extension--(OMB No. 
0920-0881, expires 3/31/14)--National Center for Emerging and Zoonotic 
Infectious Diseases (NCEZID), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    The Laboratory Response Network (LRN) was established by the 
Department of Health and Human Services, Centers for Disease Control 
and Prevention (CDC) in accordance with Presidential Decision Directive 
39, which outlined national anti-terrorism policies and assigned 
specific missions to Federal departments and agencies. The LRN's 
mission is to maintain an integrated national and international network 
of laboratories that can respond to acts of biological, chemical, or 
radiological terrorism and other public health emergencies. Federal, 
State, and local public health laboratories voluntarily join the LRN.
    The LRN Program Office maintains a database of information for each 
member laboratory that includes contact information as well as staff 
and equipment inventories. However, semiannually or during emergency 
response, the LRN Program Office may conduct a Special Data Call to 
obtain additional information from LRN Member Laboratories in regards 
to biological or chemical terrorism preparedness. Special Data Calls 
may be conducted via queries that are distributed by broadcast emails 
or by survey tools (i.e. Survey Monkey). This is a request for an 
extension to this generic clearance. The only cost to respondents is 
their time to respond to the data call. The total annual burden hours 
requested is 400 hours.

[[Page 4166]]



                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                 Avg. Burden per
        Type of  respondents               Form name             No. of       No. of responses    response  (in
                                                               respondents      per respondent        hrs.)
----------------------------------------------------------------------------------------------------------------
Public Health Laboratorians........  Special Data Call                   200                 4             30/60
----------------------------------------------------------------------------------------------------------------


Leroy Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-01409 Filed 1-23-14; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.